Purifloh Ltd (po3) Logo

Purifloh Ltd (PO3)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

PO3 Chart

PO3's Principal Activity is the developing its Free Radical Generator ("FRG") technology for a range of applications across three opportunities: Indoor air purification, Water sanitation and Medical sterilisation.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -26.86%
vs ASX 200 (1yr) -76.75%

Size

Market Capitalisation
ASX Rank 1,391 of 2,237
Sector Rank 21 of 27

Key Information

Shares Issued
Sector Utilities
Similar Companies TPC / DEL / VPR
EPS -$0.156
DPS $0.00
NTA per share -$0.01

Broker Consensus

PO3 is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

PuriflOH Limited (PO3) in conjunction with the Somnio Group, is developing its Free Radical Generator (FRG) technology for a range of applications across three opportunities: Indoor air purification, Water sanitation and Medical sterilization.

Incorporation Details

Incorporated The Company was incorporated on 15 March 2007 in Australia and is registered in Western Australia under the name Water Resources Group Limited.

Corporate Details

Head Office South Melbourne VIC 3205
Website www.purifloh.com
Registry Link Market Services
Auditor PKF BRISBANE AUDIT
Date Listed 30 Dec 2010

Upcoming Calendar

Date Event
30/08/2021 Report (Prelim)
16/09/2021 Report (Annual)
25/02/2022 Report (Interim)

Dividend History

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Jonathon (Jon) Evans Non-Executive Director Oct 2020 Director Bio icon

Mr Jonathon (Jon) Evans

Non-Executive Director

Mr Evans has a range of experience in healthcare, medical research and the innovation and commercialisation of IP and related technology solutions across the Australian and broader Asia Pacific Region. His career spans over 30 years, including as CEO of an Australian Hospital Group; Director of a State-based Infectious Disease Reference Laboratory; CEO of Tellimed Health Services; Director of Health Strategy and Innovation for Victorian Government; Managing Partner of Fitzroy Health Asia Pacific- an Australian/US Health Commercialisation company and most recently as Managing Director, APAC Health Solutions Group. Mr Evans is also chairman of CEMTAS Australia.

Professor Pravansu Mohanty Non-Executive Director Nov 2019 Director Bio icon

Professor Pravansu Mohanty

Non-Executive Director

Prof Mohanty is a founding partner and co-owner of Somnio Global. He is the Paul K Trojan Collegiate Professor of Engineering at the University of Michigan. He has research interests in the areas of Additive Manufacturing, Plasma/ Laser Materials Processing, Biomaterials, Nanostructured Materials and Functionally Designed Materials for Energy Storage and Energy Generation. He has published numerous scientific papers, patents and received many research grants from Federal agencies including the National Science Foundation, US Army, US Navy, and Dept. of Energy. In 2015, Professor Mohanty was awarded an honor for non-resident Indians, the Hind Rattan (Jewel of India) Award for his contribution to science and engineering, presented to him at the Republic Day of India Celebration in New Delhi.

Mr Carl Le Souef Non-Executive Director,Interim Chairman Nov 2019 Director Bio icon

Mr Carl Le Souef

Non-Executive Director,Interim Chairman

Mr Souef is a founding partner and co-owner of Somnio Global. He oversaw the restructuring of PuriflOH (previously known as Water Resources Group Limited) during 2013/2014, which resulted in Dilato Holdings Pty Limited emerge as the major shareholder of PuriflOH, a position it still retains. Dilato Holdings is Mr. Le Souef's private investment company. Mr. Le Souef was previously the sole owner and CEO of one of Australia's largest privately owned FMCG organisations, Private Formula International, a global operation that included Australia's number one selling skincare range at the time, Dr LeWinn's Private Formula. In 2009, he negotiated the sale of the company to a US based pharmaceutical major. Mr Le Souef maintains an executive role in Somnio Global and in the management of his family office investments.

Mr Simon Richard Lill Executive Director,Company Secretary Sep 2013 Director Bio icon

Mr Simon Richard Lill

Executive Director,Company Secretary

Mr Lill has a background of over 30 years of stockbroking, capital raising, management, business development and analysis for a range of small and start-up companies, in both the manufacturing and resources industries. He has assisted Mr Le Souef in the restructuring of the Company in 2013 and has managed the Company's Australian affairs since that time. He has similarly assisted the restructure of De Grey Mining Limited from his appointment in 2013 and is now Chairman of that Company. Mr Lill has been, or is, a director of the following: De Grey Mining Limited (appointed 2 October 2013, continuing) Mejority Capital Limited (appointed 18 May 2010; resigned 25 November 2019) XPD Soccer Gear Group Limited (appointed 29 March 2018, continuing).

Director Transactions

PO3 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
20/05/20 Simon Lill Buy +2,000 $2.30 $4,600 On-market trade
15/05/20 Simon Lill Buy +2,970 $2.25 $6,682 On-market trade
22/11/19 Simon Lill Issued 32,500 $2.40 $78,000 Director remuneration
22/11/19 William (Bill) Parfet Issued 11,684 $3.72 $43,467 Director remuneration

Director Interests

The current holdings of PO3 directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Carl Le Souef 30/06/2020 N/A 18,409,194 N/A N/A
Simon Lill 30/06/2020 288,720 N/A N/A N/A
Pravansu Mohanty 22/11/2019 0 N/A N/A N/A
Jonathon (Jon) Evans N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Sep 17, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Dilato Holdings Pty Ltd 18,409,194 58.66%
Upjohn Laboratories Llc 5,271,601 16.80%
Andra M Rush 650,000 2.07%
Holbrook Corporation Pty Ltd 402,206 1.28%
Riveck Nominees Pty Ltd 342,555 1.09%
Gemtara Investments Pty Ltd 305,576 0.97%
Citicorp Nominees Pty Limited 291,445 0.93%
Steven Annear 285,597 0.91%
Targo Holdings Pty Ltd 245,250 0.78%
HSBC Custody Nominees (Australia) Limited 241,855 0.77%
Lampam Pty Ltd 170,000 0.54%
Hopetoun Nominees Pty Ltd 166,000 0.53%
Anthony Mark Van Der Steeg 164,921 0.53%
Malcolm Richmond 159,965 0.51%
Saul Zaidman 140,445 0.45%
Isamg Pty Ltd 135,850 0.43%
Ferkel Pty Ltd 121,100 0.39%
Raymond Micallef 114,000 0.36%
Credal International Ltd 113,895 0.36%
Ranchland Holdings Pty Ltd 100,000 0.32%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 546 275 66 90 19 996

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Dilato Holdings Pty Ltd 17/09/2020 18,409,194 58.66
Upjohn Laboratories LLC 17/09/2020 5,271,601 16.80

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $2.90 30 June
2019 $3.35 28 June
2018 $0.435 29 June
Page Icon
PO3 Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.